Catheter Precision Inc. (VTAK) - Total Liabilities
Based on the latest financial reports, Catheter Precision Inc. (VTAK) has total liabilities worth $9.21 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Catheter Precision Inc. liquidity resilience to evaluate the company's liquid asset resilience ratio.
Catheter Precision Inc. - Total Liabilities Trend (2016–2025)
This chart illustrates how Catheter Precision Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Catheter Precision Inc.'s balance sheet.
Catheter Precision Inc. Competitors by Total Liabilities
The table below lists competitors of Catheter Precision Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cyclerion Therapeutics Inc
NASDAQ:CYCN
|
USA | $1.84 Million |
|
Gibui Holdings Ltd
TA:GIBUI
|
Israel | ILA355.21 Million |
|
Erayak Power Solution Group Inc. Class A Ordinary Shares
NASDAQ:RAYA
|
USA | $24.18 Million |
|
Kiplin Metals Inc
V:KIP
|
Canada | CA$24.99K |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
USA | $16.20 Million |
|
Cosmo Metals Ltd
AU:CMO
|
Australia | AU$645.79K |
|
Ceylon Graphite Corp
V:CYL
|
Canada | CA$4.96 Million |
|
Oryx International Growth Fund
LSE:OIG
|
UK | GBX4.67 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Catheter Precision Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Catheter Precision Inc. to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Catheter Precision Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Catheter Precision Inc. (2016–2025)
The table below shows the annual total liabilities of Catheter Precision Inc. from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $9.21 Million | -42.49% |
| 2024-12-31 | $16.01 Million | +67.80% |
| 2023-12-31 | $9.54 Million | +25.96% |
| 2022-12-31 | $7.58 Million | +2.78% |
| 2021-12-31 | $7.37 Million | -40.03% |
| 2020-12-31 | $12.29 Million | +12.44% |
| 2019-12-31 | $10.93 Million | +49.13% |
| 2018-12-31 | $7.33 Million | -61.18% |
| 2017-12-31 | $18.88 Million | +203.50% |
| 2016-12-31 | $6.22 Million | -- |
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more